Profit Track 100

This company supports the development of medicines and medical devices from conception through to regulatory approval and marketing. It specialises in rare diseases, stem cell therapies and oncology. With offices in Hampshire, Ireland and Japan, it assembles the most suitable team for each project from a network of more than 800 freelance experts and small companies globally. Founded in 2000 by wife-and-husband team Julie and Mike Matthews, 68 and 67 respectively, it grew profits to £3 million last year.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyTMC Pharma
ActivityPharmaceutical development services
Annual profit growth42.39%
Latest profits £000s*3,017
Latest sales £000s*14,307

If applicable:

* supplied by company † annualised figure ‡ profits = ebitda